The treatment of Acne & Ulcerative Colitis with vitamins

Acne and Ulcerative Colitis: Mitamins custom make quality formulas for the treatment of Acne & Ulcerative Colitis with vitamins. A Acne & Ulcerative Colitis formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Acne and Ulcerative Colitis

  • Amount Per Serving
    % DV
    Vitamin A
    2500
    IU
    50%
    Vitamin E
    100
    IU
    333%
    Vitamin B6
    50
    mg
    2500%
    Zinc
    10
    mg
    67%
    Selenium
    100
    mcg
    143%
    Copper
    1
    mg
    50%
    Chromium
    100
    mcg
    83%
  • Amount Per Serving
    % DV
    Lactobacillus acidolphilus
    50
    mg
    *
    L-Glutamine
    50
    mg
    *
    Turmeric Extract
    50
    mg
    *
    Psyllium
    50
    mg
    *
    Bromelain
    50
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice

Acne and Ulcerative Colitis Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Mass General Hospital Testing New Epilepsy Therapy Device - Clinical Trial Examines New Responsive Brain Stimulation Technology
In an effort to find a better therapy and improve the lives of people with epilepsy, the Massachusetts General Hospital (MGH) Epilepsy Service is participating in the RNS? System Pivotal Clinical Investigation, a study to evaluate the safety and effectiveness of a responsive brain stimulation device in reducing the frequency of uncontrolled seizures.
Genmab Amends Ofatumumab Pivotal Study In NHL To Single Arm Study
Genmab A/S (OMX: GEN) announced it has amended the design of an ongoing pivotal study of ofatumumab (HuMax-CD20(R)) in rituximab refractory follicular non Hodgkin's lymphoma (NHL) to a single arm trial that will now include approximately 81 patients. All patients will receive one infusion of 300 mg of ofatumumab followed by 7 weekly infusions of 1000 mg of ofatumumab.
This information concerning the support of Acne and Ulcerative Colitis treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments